Introduction
Although neuropathic pain is a common complication of traumatic brachial plexus injury [1] , the prevalence and characteristics of neuropathic pain are not well documented. Previous studies that investigated pain in patients with traumatic brachial plexus injury did not use widely agreed-upon methods for the diagnosis of neuropathic pain in epidemiological surveys (e.g., validated screening tools) and did not provide information on the different types of neuropathic pain, nor did they investigate to what extent this condition affects quality of life or causes depression [2] [3] [4] [5] . Having more information on the frequency of neuropathic and nonneuropathic pain and how pain is associated with reduced quality of life and depression might prompt neurologists to screen patients for these brachial plexopathy complications and adopt the best treatment.
This prospective hospital-based multicenter study was designed to seek more reliable information on the prevalence and characteristics of neuropathic pain due to traumatic brachial plexus injury. To do so, all the patients enrolled underwent a bedside clinical examination and neurophysiological testing for a definitive diagnosis of the brachial plexus injury, the DN4 screening tool questionnaire to identify neuropathic pain [6] , and the Neuropathic Pain Symptom Inventory to distinguish the different types of neuropathic pain [7] .
Methods
In an observational study conducted from October 2010 to December 2013, we screened 129 patients with traumatic brachial plexus injury attending five hospitals. In these five hospitals, all medical staff referred patients with possible traumatic brachial plexus injury to five neurologists (PC, LP, GD, ER, ST) for the clinical assessment and the neurophysiological testing. Inclusion criteria were a diagnosis of traumatic plexus injury, age over 18 years, and informed consent. The diagnosis of traumatic brachial plexus injury was based on clinical and neurophysiological criteria, according to standardized protocols and recommendations established by the Guidelines of the American Academy of Neurology [8] . In particular, the diagnosis was based on the clinical evidence of post-traumatic loss of sensation and muscle weakness involving shoulder and upper limb and neurophysiological testing showing damage of brachial plexus nerve trunks. Exclusion criteria were cognitive disturbances and concomitant peripheral or central nervous system diseases. Among the 129 patients initially screened, we excluded 22 patients (nine had concomitant traumatic neuropathies, three diabetic polyneuropathy, eight traumatic brain injury, and two cognitive disturbances). We therefore enrolled 107 patients with traumatic brachial plexus injury definitely diagnosed with clinical examination and neurophysiological testing. The study was conducted in accordance with the Helsinki Declaration, and informed consent was obtained before the examination. The study was approved by the institutional review boards at the participating hospitals.
Clinical and Neurophysiological Examination
The clinical examination included sensory profiling using bedside tools. We investigated touch with a piece of cotton wool, vibration with a tuning fork (128 Hz), and pinprick sensation with a wooden cocktail stick. We collected the Medical Research Council (MRC) score for muscle strength applied to the upper limb muscles. The neurophysiological investigation included sensory nerve action potentials and conduction velocities recorded from the median (I and III digits), ulnar (V digit), superficial radial nerves, and lateral and medial antebrachial cutaneous nerves. We also tested compound motor action potential amplitudes and conduction velocities from the median, ulnar, musculocutaneous, suprascapular, circumflex and long thoracic nerves. The electromyography was applied to the deltoid, infra/supraspinatus, anterior dentatus, biceps brachial, triceps brachial, brachioradial, extensor digitorum communis and indicis, flexor carpi ulnaris, flexor digitorum profundus, abductor pollicis brevis, and first dorsal interosseous muscles.
Pain Assessment and Questionnaires
Patients were asked to report pain experienced at the time of assessment. The DN4 questionnaire for neuropathic pain was administered to all patients with pain. Patients who scored a 4 or higher on the DN4 (thus diagnosed as suffering from neuropathic pain) completed the Neuropathic Pain Symptom Inventory. The subscores of the Neuropathic Pain Symptom Inventory were calculated for the different clinical symptoms: spontaneous, paroxysmal or provoked pains, and abnormal sensations.
In patients with neuropathic pain, we also calculated the SF36 and the 21-item BDI II scores. According to the BDI score, depression was rated as minimal-moderate (range ¼ 14-19), moderate-severe (range ¼ 20-29), or severe (range ¼ 30-63).
As primary outcome variables, we analyzed the prevalence of neuropathic pain, as assessed with the DN4, and the different neuropathic pain qualities, as assessed with the Neuropathic Pain Symptom Inventory. As secondary outcome variables, we investigated whether age and the severity of peripheral nerve damage were associated with neuropathic pain. Among the different neurophysiological variables, we used the amplitude of the sensory nerve action potential relative to the predominantly damaged brachial plexus component as being representative of the severity of peripheral nerve damage [8] . We also compared the SF36 items in our patients with those of the Italian SF36 normative reference data [9] and investigated the frequency of depression using the BDI.
Statistical Analysis
The differences in frequency among the various types of pain, as assessed with Neuropathic Pain Symptom Inventory, were analyzed by using the chi-square test. We used the Mann-Whitney test to compare age and amplitude of the sensory nerve action potentials between patients with and those without neuropathic pain. Differences in gender frequency between patients with and those without neuropathic pain were analyzed by
Results
During the three-year study, we enrolled 107 patients (85 M, 22 F; 16-79 years, mean age 42.4 612.3 years; education level: three patients with primary education, 98 secondary education, six higher education) with a definitive clinical and neurophysiologically documented diagnosis of traumatic brachial plexus injury. Although the primary upper trunk was the most frequently damaged brachial plexus component (66% of patients had a primary trunk lesion), virtually all the patients (95%) had a multiple-level injury.
Of the 107 patients investigated, 74 had pain (69%). According to the DN4 questionnaire, 60 of these patients experienced neuropathic pain (56%) ( Table 1 ). The Neuropathic Pain Symptom Inventory showed that the most frequent and severe type of pain was spontaneous ongoing burning pain (P < 0.01, by the chi-square test) ( Table 2 ).
While age did not differ between patients with and those without neuropathic pain, patients with neuropathic pain had a lower sensory nerve action potential amplitude than those without (P ¼ 0.03, by Mann-Whitney test). Patients with neuropathic pain scored lower in all domains of the SF36 than the Italian SF36 normative references (P < 0.001, by the unpaired t test with Welch's correction) ( Table 3) . Of the 60 patients with neuropathic pain, 29 (48%) suffered from depression, as demonstrated by a BDI score higher than 14.
Discussion
Our prospective hospital-based multicenter study, using bedside clinical examination, neurophysiological testing, and widely agreed criteria for the diagnosis of neuropathic pain, provides reliable information on the prevalence of neuropathic pain. Our results, obtained from a large population, confirm that neuropathic pain is a common complication after traumatic brachial plexus injury and that it frequently manifests as spontaneous ongoing burning pain. We also provide the previously unavailable evidence that pain due to traumatic brachial plexus injury is related to the severity of peripheral nerve damage.
Our study, which shows that 56% of the patients enrolled suffered from neuropathic pain, argue against previous observations, which reported a prevalence of neuropathic pain ranging from 70% to 84% [2] [3] [4] [5] . However, in most of these studies patients were enrolled in surgical departments, thus raising the possibility of a selection bias: Only patients with more severe lesion and the need of surgical treatment have been probably included in these studies. Furthermore, in most of these studies the diagnostic criteria of brachial plexus lesion and neuropathic pain were poorly detailed.
In our study, we prospectively enrolled patients with brachial plexus injury admitted to hospital departments, we definitely diagnosed brachial plexus injury with clinical examination and widely agreed neurophysiological criteria, and we used the DN4 questionnaire, a highly specific tool that distinguishes neuropathic and nociceptive pain. We therefore believe that the findings of our study are reliable and our sample of patients is an unbiased representative of the population with traumatic brachial plexopathy.
The Neuropathic Pain Symptom Inventory showed that the most frequent type of pain in our patients with traumatic brachial plexus injury was the spontaneous burning pain. This finding is likely to reflect the specific type of peripheral nerve damage caused by traumatic brachial plexus injury. Such lesions frequently affect also the cell body or the postganglionic axon [10, 11] , leaving the second-order postsynaptic membrane exposed to local transmitters, which in turn gives rise to spontaneous firing [10] . Recordings from dorsal horn neurons in a patient with pain due to dorsal root damage caused by trauma to the cauda equina consistently showed high-frequency regular and paroxysmal bursting discharges. This patient complained of spontaneous burning pain in an anaesthetized region [12] .
We found that the amplitude of sensory nerve action potentials was lower in patients with neuropathic pain than in those without. This finding suggests that neuropathic pain is associated with the severity of peripheral nerve damage; that is, the more severe the peripheral nerve damage, the more likely the patient is to suffer from neuropathic pain. This finding is in line with the results of previous studies, in which the prevalence of pain was higher in more severe traumatic nerve injuries [1] . Because nerve conduction study provides information on non-nociceptive Ab-fiber damage, our finding might indirectly reflect the association between neuropathic pain and the severity of nociceptive fiber damage. The possibility that non-nociceptive Ab-fiber loss causes neuropathic pain through disinhibition of the nociceptive system cannot, however, be ruled out. For instance, a preexisting polyneuropathy that affects Ab fibers is a risk factor for developing chronic postherpetic pain [13] .
As expected, the SF36 questionnaire and BDI showed that in patients with neuropathic pain the quality of life was worse than in the reference Italian population and that depression was frequent. These findings are in keeping with the many observations showing that neuropathic pain impairs quality of life and is associated with mood disturbances [14, 15] . Consequently, pharmacological treatment in patients with neuropathic pain due to traumatic brachial plexus injury should also be aimed at these comorbidities.
Admittedly, a limitation of our study is that we did not collect SF36 and BDI in patients with non-neuropathic pain, and thus we could not compare these outcome measures between patients with the two types of pain.
Conclusions
Our study shows that traumatic brachial plexus injury commonly causes neuropathic pain as assessed with clinical examination and DN4 questionnaire. In these patients, neuropathic pain is associated with more severe peripheral nerve damage. Several patients with traumatic brachial plexus injury, however, suffer from nociceptive, non-neuropathic pain, and thus neurologists should distinguish with clinical examination and DN4 questionnaire patients with neuropathic and nociceptive pain and consequently adopt the best treatment.
In patients with traumatic brachial plexus injury, neuropathic pain commonly impairs quality of life and causes depression, and thus treatment should also be aimed at these comorbidities. 
